Agios Pharmaceuticals | AGIO - 销售收入



金融业
股票价格
USD
资产
USD 1.11B
现金及等价物
USD 99.65M
销售成本
USD 1.32M
流动资产
USD 717.67M
流动负债
USD 70.22M
债务
USD 35.75M
EBIT
USD -110.03M
EBITDA
USD -108.66M
员工
486
EPS每股收益
USD -1.69
股本和储备
USD 1.03B
销售毛利
USD 19.43M
债务利息支出
USD 1.11B
利息收入
USD 10.8M
贷款资金
USD 1.06M
市值
USD 1.93B
净收入
USD -99.11M
营业费用
USD 130.77M
营业利润
USD -110.03M
普通股股本
USD 59.34M
PE价格收益
3.56
税前利润
USD -99.11M
销售收入
USD 44.74M
销售和管理费用
USD 38.46M
股票
USD 35.75M
贸易债权人
USD 16.35M
应收帐款人
USD 16.13M


销售 更改 日
AbbVie USD 16.99B 1.99B 2026-06
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amgen USD 10.1B 1.48B 2026-06
Arrowhead Research USD 75.23M 1.49M 2026-06
Astellas Pharma JPY 640.91B 102.98B 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Bayer EUR 10.87B 2.54B 2026-06
Biogen USD 2.74B 490M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Daiichi Sankyo JPY 574.74B 12.26B 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Exelixis USD 628.69M 17.89M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Incyte USD 1.67B 400M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Merck USD 16.6B 310M 2026-06
Moderna USD 100M 289M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Novartis USD 13.11B 750M 2026-03
Pfizer USD 15.03B 530M 2026-06
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06